Regeneron Pharmaceuticals (REGN) Securities Class Action Hagens Berman Highlights Lawsuit Targeting Regeneron Pharmaceuticals (REGN) Over Alleged Misleading Statements SAN FRANCISCO, Sept. 12, 2026 (GLOBE NEWSWIRE) — Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has…
Latest News
Editor' Pick
Prime Minister Mark Carney will gather scores of deep-pocketed investors in Toronto…
Just In
The late Princess Diana‘s infamous “revenge dress,” which she wore the same…
Canada News
By Tori Fitzpatrick The Canadian Press Posted September 11, 2026 4:06 pm 1 min read Descrease article font size Increase article font size The…
Lifestyle
Canada’s first centre dedicated to supporting people with dyslexia is getting a permanent home in Vancouver with a focus on…
Tech & Innovation
On September 6th, YouTuber Nicholas Light posted a video to one of his channels that made it seem like all of his content was about to…
Entertainment
Descrease article font size Increase article font size Judge Judy Sheindlin is…
